Lanoxin Pg

Digoxin, the active ingredient in Lanoxin Pg, is a cardiac glycoside presented as an oral tablet for oral use. It is employed in the management of certain heart conditions, notably heart failure and atrial fibrillation, to improve cardiac contractility and control ventricular rate. It is commonly prescribed under careful medical supervision.

GNH USA supplies Lanoxin Pg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Digoxin acts on the cardiac conduction system and myocardial contractility, making it useful in specific cardiovascular conditions.

- Heart failure: improves symptoms, exercise tolerance and may reduce hospitalizations. - Atrial fibrillation: helps control ventricular rate and can improve functional capacity. - Atrial flutter: assists in ventricular rate control during rapid atrial response.

Digoxin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Fatigue - Blurred vision - Headache

Serious or Rare Side Effects: - Cardiac arrhythmias - Severe bradycardia - Heart block - Hyperkalemia - Anaphylactic reaction - Color vision disturbances (e.g., yellow‑green halos)

When using digoxin, clinicians should observe several safety measures to minimize risk.

- Monitor serum digoxin level: adjust dose based on therapeutic range. - Assess renal function: dose may need reduction in impairment. - Check electrolytes, especially potassium: hypokalemia increases toxicity risk. - Use caution in elderly patients: increased sensitivity to effects. - Avoid overdose: follow prescribing instructions precisely. - Store at ambient temperature: keep in original container, protect from moisture.

Digoxin interacts with several medicines that can alter its plasma concentration or cardiac effects.

Major Interactions (Avoid): - Amiodarone: markedly increases digoxin levels, raising toxicity risk. - Quinidine: raises digoxin concentration and may precipitate arrhythmias. - Verapamil: enhances digoxin effect and risk of bradycardia.

Moderate Interactions (Monitor Closely): - Loop diuretics (e.g., furosemide): may cause electrolyte shifts affecting digoxin. - ACE inhibitors (e.g., enalapril): can increase digoxin levels. - Beta‑blockers (e.g., metoprolol): additive slowing of heart rate. - NSAIDs (e.g., ibuprofen): may reduce renal clearance of digoxin.